Professor Catherine McBain
Professor McBain graduated from University of Manchester Medical School in 1994.
She then held house officer and senior house officer posts at Manchester Royal Infirmary, Wythenshawe Hospital, Whiston Hospital (St Helens) and Salford Royal, and gained her Membership of the Royal College of Physicians in February 1997.
Professor McBain joined The Christie in August 1997 as a Specialist Registrar and passed her final Fellowship of Royal College of Radiologists examinations in 2000. She then carried out two years full-time research in technical aspects of image-guided radiotherapy at the University of Manchester Academic Department of Radiation Oncology and was awarded her MD in 2005. Professor McBain was appointed as a consultant in May 2005 and has since led service development for primary brain and CNS tumours, working closely with neurosurgical teams at Salford Royal Foundation Trust and with commissioners to establishment site-specific multi-disciplinary teams and NICE-compliant referral and treatment pathways.
Professor McBain was instrumental in the establishment of the Stereotactic Radiosurgery service at The Christie at Salford which opened in 2011. She is committed to improving outcomes in brain tumours and is principal investigator for a portfolio of clinical trials in this field. She is also a member of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumour Group and the National Cancer Research Network (NCRN) Brain Clinical sub-group, as well as the American Society for Neuro-oncology.
Professor McBain is the Greater Manchester, South Lancashire and Cumbria representative on the National Specialised Commissioning Brain and CNS Clinical Reference Group. She continues to practise colo-rectal oncology, delivering chemotherapy and biological therapies via a weekly clinic at The Macmillan Cancer Resource Centre at Macclesfield Hospital and supervises rectal radiotherapy for patients from Macclesfield and Leighton hospitals.
Claire has been working at GM Cancer for over three years as a pathway manager, facilitating five pathway boards to deliver system wide improvements to cancer pathways and patient care, including Breast, Head and Neck, Genomics, Neuro-oncology and Hepato-Pancreato-Biliary. The boards offer an objective and collaborative approach to service improvement and bring together stakeholders from across Greater Manchester to create an engaged, multidisciplinary board which is representative of the whole patient pathway.
Prior to working at GM Cancer, Claire worked at Cancer Research UK as their Northwest Clinical Research Associate, covering a range of early phase clinical trials. Claire has also held roles at The Christie Clinical Trials Unit and Macmillan building a wealth of experience in clinical cancer research and service improvement.
Claire has also qualified as a coach and mentor with the Chartered Management Institute and supports colleagues within The Christie Leadership Framework and leadership of the GM Cancer administrative function.